Pathogen News and Research

RSS

SARS-CoV-2's RNA folding structures are potential therapeutic targets, study finds

A team of researchers at Goethe University in Germany has observed the RNA folding structures of the SARS-CoV-2 genome that aids the infection process.

24 Nov 2020

COVID-19 study underscores the importance of protection guidelines based on fluid dynamics research

Researchers who study the physics of fluids are learning why certain situations increase the risk that droplets will transmit diseases like COVID-19.

24 Nov 2020

New zinc oxide surface kills airborne viruses and bacteria

They burst out of toilet bubbles, swim across drinking water, spread through coughs. Tiny infectious microbes--from the virus that causes COVID-19 to waterborne bacteria--kill millions of people around the world each year.

24 Nov 2020

Researchers conduct aerosol characterization experiments to protect healthcare workers from COVID-19

The rapid spread of COVID-19 overwhelmed hospitals that were unable to contend with the increasing number of patients, many requiring ventilators and other critical care. Such conditions can put medical workers at risk. Now researchers are studying methods to increase hospital safety and efficacy during the pandemic.

24 Nov 2020

SARS-CoV-2's spike protein mutations have slowed, study finds

A team of researchers at the School of Information Sciences in Illinois, USA, has revealed the rate of mutation in the 29 proteins that make up the SARS-CoV-2 microbe.

23 Nov 2020

Modified SARS-CoV-2 receptor-binding domain could increase vaccine efficacy, says study

A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2 vaccines. Their study, which was released on the bioRxiv* in November 2020, may help advance even more efficacious SARS-CoV-2 vaccine candidates in the future.

23 Nov 2020

Researchers develop recombinant SARS-CoV-2 model to aid vaccine and antiviral research

Researchers have developed a fluorescent reporter gene-bearing recombinant form of SARS-CoV-2, which is capable of replication.

23 Nov 2020

Chicago seroprevalence study shows COVID-19 cases 16 times higher than currently predicted

A startling new case study of Chicago, led by a team of researchers at Northwestern University in Illinois, USA, suggests a 16-fold higher incidence of SARS-CoV-2 infection than previously thought. This is judging from seroprevalence (antibody presence blood testing) figures, rather than the number of RT-PCR-positives reported there (via swab sample testing of symptomatic patients).

23 Nov 2020

Compounds in traditional Chinese medicine herbs may inhibit SARS-CoV-2 infection

Using computational methods, a team of researchers identified three compounds in traditional Chinese medicine that could be used against SARS-CoV-2.

23 Nov 2020

Sage and perilla herbal teas could help to prevent or treat COVID-19

Researchers in Germany have conducted a study demonstrating the potential antiviral effects of commonly consumed herbal teas on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the pathogen that causes coronavirus disease 2019 (COVID-19).

22 Nov 2020

SARS-CoV-2 suppresses ACE2 activity in COVID-19 patients

A recent study conducted by a team of international scientists has revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), suppresses the expression and function of human angiotensin-converting enzyme 2 (ACE2) and induces the expression of interferon-stimulated genes at the initial phase of infection. The study is currently available on the bioRxiv* preprint server.

20 Nov 2020

Furin inhibition may mitigate severe COVID-19, study finds

Dr. Kara Fitzgerald, a researcher at the Institute for Functional Medicine in the United States, has explained the role of furin protease in developing severe COVID-19 illness.

20 Nov 2020

How effective have COVID-19 mitigation strategies been in Australia's second wave?

Researchers have modeled the effect of the different types of social distancing implemented in Australia's greater Melbourne area in response to the county's second wave of coronavirus disease 2019 (COVID-19) cases. They found implementing stricter lockdowns in the beginning before the rapid rise in cases works best. The team's findings have been made available on the preprint server, medRxiv*.

20 Nov 2020

Pathogen News and Research

SARS-CoV-2's RNA folding structures are potential therapeutic targets, study finds

COVID-19 study underscores the importance of protection guidelines based on fluid dynamics research

New zinc oxide surface kills airborne viruses and bacteria

Researchers conduct aerosol characterization experiments to protect healthcare workers from COVID-19

SARS-CoV-2's spike protein mutations have slowed, study finds

Modified SARS-CoV-2 receptor-binding domain could increase vaccine efficacy, says study

Researchers develop recombinant SARS-CoV-2 model to aid vaccine and antiviral research

Chicago seroprevalence study shows COVID-19 cases 16 times higher than currently predicted

Compounds in traditional Chinese medicine herbs may inhibit SARS-CoV-2 infection

Sage and perilla herbal teas could help to prevent or treat COVID-19

SARS-CoV-2 suppresses ACE2 activity in COVID-19 patients

Furin inhibition may mitigate severe COVID-19, study finds

How effective have COVID-19 mitigation strategies been in Australia's second wave?

Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19

Seroprevalence meta-analysis predicts 643 million already infected by SARS-CoV-2 globally

Researchers uncover potential new target to fight inflammatory diseases

The impact of the COVID-19 pandemic on those with OCDs

SARS-CoV-2 immunity can last over six months, study finds

Triple RNA sequencing dissects gene expression of virus and fungi in infection processes

TB researchers uncover crucial clue that explains antibiotic resistance in bacteria

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News